(Cross-) Contamination Control Through Effective Equipment Cleaning

By Dirk-Jan van Zoelen, Ph.D., Business Unit Director API, Oss, The Netherlands

As pharmaceutical manufacturing moves from laboratory scale to multi‑kilogram production, managing cross‑contamination becomes critical—particularly in multipurpose, multiproduct facilities handling compounds with limited safety data. Effective equipment cleaning is a cornerstone of patient safety, regulatory compliance, and operational flexibility. A structured, risk‑based cleaning strategy addresses multiple contamination sources, from insufficient residue removal to mechanical and airborne transfer. Health‑based exposure limits now play a central role in defining acceptable carryover, replacing fixed, one‑size‑fits‑all thresholds. By combining calculated residue limits, equipment cleanability assessments, targeted cleaning procedures, and robust monitoring, manufacturers can tailor cleaning requirements to each product changeover.

This approach supports rapid introduction of developmental processes without compromising ongoing production. Validated worst‑case models further strengthen confidence that cleaning processes remain effective as portfolios evolve. Together, these practices show how modern cleaning validation enables efficient scheduling, faster transitions between products, and reliable contamination control—balancing speed and flexibility with rigorous GMP expectations in today’s complex manufacturing environments.